BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12152986)

  • 1. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked lymphoproliferative disease: a progressive immunodeficiency.
    Morra M; Howie D; Grande MS; Sayos J; Wang N; Wu C; Engel P; Terhorst C
    Annu Rev Immunol; 2001; 19():657-82. PubMed ID: 11244050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
    Schuster V; Kreth HW
    Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XLP: one gene, many players.
    Czar MJ; Schwartzberg PL
    Clin Immunol; 2001 Jul; 100(1):2-3. PubMed ID: 11414739
    [No Abstract]   [Full Text] [Related]  

  • 7. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
    Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
    Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene.
    Coffey AJ; Brooksbank RA; Brandau O; Oohashi T; Howell GR; Bye JM; Cahn AP; Durham J; Heath P; Wray P; Pavitt R; Wilkinson J; Leversha M; Huckle E; Shaw-Smith CJ; Dunham A; Rhodes S; Schuster V; Porta G; Yin L; Serafini P; Sylla B; Zollo M; Franco B; Bolino A; Seri M; Lanyi A; Davis JR; Webster D; Harris A; Lenoir G; de St Basile G; Jones A; Behloradsky BH; Achatz H; Murken J; Fassler R; Sumegi J; Romeo G; Vaudin M; Ross MT; Meindl A; Bentley DR
    Nat Genet; 1998 Oct; 20(2):129-35. PubMed ID: 9771704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus.
    Howie D; Sayos J; Terhorst C; Morra M
    Curr Opin Immunol; 2000 Aug; 12(4):474-8. PubMed ID: 10899030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and immunological basis of X-linked lymphoproliferative disease.
    Latour S; Veillette A
    Immunol Rev; 2003 Apr; 192():212-24. PubMed ID: 12670406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells.
    Parolini S; Bottino C; Falco M; Augugliaro R; Giliani S; Franceschini R; Ochs HD; Wolf H; Bonnefoy JY; Biassoni R; Moretta L; Notarangelo LD; Moretta A
    J Exp Med; 2000 Aug; 192(3):337-46. PubMed ID: 10934222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The X-linked lymphoproliferative syndrome gene product SH2D1A associates with p62dok (Dok1) and activates NF-kappa B.
    Sylla BS; Murphy K; Cahir-McFarland E; Lane WS; Mosialos G; Kieff E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7470-5. PubMed ID: 10852966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A "three-pronged" binding mechanism for the SAP/SH2D1A SH2 domain: structural basis and relevance to the XLP syndrome.
    Hwang PM; Li C; Morra M; Lillywhite J; Muhandiram DR; Gertler F; Terhorst C; Kay LE; Pawson T; Forman-Kay JD; Li SC
    EMBO J; 2002 Feb; 21(3):314-23. PubMed ID: 11823424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
    Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
    Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-causing SAP mutants are defective in ligand binding and protein folding.
    Li C; Iosef C; Jia CY; Gkourasas T; Han VK; Shun-Cheng Li S
    Biochemistry; 2003 Dec; 42(50):14885-92. PubMed ID: 14674764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease.
    Wu C; Sayos J; Wang N; Howie D; Coyle A; Terhorst C
    Immunogenetics; 2000 Aug; 51(10):805-15. PubMed ID: 10970095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients.
    Yin L; Ferrand V; Lavoué MF; Hayoz D; Philippe N; Souillet G; Seri M; Giacchino R; Castagnola E; Hodgson S; Sylla BS; Romeo G
    Hum Genet; 1999 Nov; 105(5):501-5. PubMed ID: 10598819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
    Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
    Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.